Trial Profile
The clinical study to explore the effecs of anagliptin on responses of plasma glucose and lipid in new-onset type 2 diabetic patients
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 08 Jan 2015
Price :
$35
*
At a glance
- Drugs Anagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 07 Jan 2015 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.
- 14 Jul 2014 New trial record